The Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) stands as a formidable force reshaping the U.S. biomanufacturing sector amid the demand for sustainable and efficient biotechnological solutions. Since its inception in 2009 under the U.S. Department of Energy's Bioenergy
When it comes to the rapidly evolving field of cell and gene therapy (CGT), Ivan Kairatov stands out as a seasoned expert with significant insight into technological advances and strategic partnerships. His expertise is pivotal in understanding Matica Bio’s collaboration with Texas A&M’s National
The European Union is experiencing a notable shift within its medical device sector due to evolving regulatory frameworks, sparked by developments expected by early 2025. Beginning with a focus on key regulatory updates and industry responses, this transformation is deeply rooted in the frameworks
Introducing Ivan Kairatov, a distinguished authority in biopharmaceutical innovation and technological advancements. With extensive experience in research and development, Ivan provides a unique perspective on the acquisition of Althea by PCI Pharma. This interview delves into how such strategic
As the alternative protein industry strives to capture a significant share of the global protein market by 2035, optimizing bioprocessing emerges as a critical task. In an era where innovation is driven by sustainability and efficiency, manufacturers find themselves relying heavily on pump
The current landscape of the scientific and pharmaceutical industries presents a fascinating blend of unprecedented advancements and complex challenges that continue to redefine the sector. As these industries evolve, they encounter critical opportunities for growth alongside significant hurdles
